Impact of Bluetooth-enabled versus traditional glucometers on glycaemic control in adults with insulin-treated diabetes integrated with telehealth in personalized diabetes management: a randomized controlled trial

Effectiveness of a Bluetooth-enabled glucometer which automatically syncs blood glucose readings to a mobile app, on adults with diabetes mellitus for glycaemic control (HbA1c), diabetes-related distress, satisfaction and cardiometabolic parameters, as compared to using a traditional glucometer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN69173566

Enrollment

120

Registered

2024-12-16

Start date

2022-02-21

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus Nutritional, Metabolic, Endocrine

Interventions

This interventional study was a 6-month, single-centre, two-armed, open-labelled parallel randomized controlled trial, where participants with diabetes mellitus newly started on insulin or requiring i

Eligibility

Sex/Gender

All

Age

21 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with diabetes mellitus and on insulin treatment, which is being newly-initiated or require significant dose adjustment 2. Patients of a tertiary hospital in Singapore (Tan Tock Seng Hospital) during their inpatient stay or routine outpatient clinic visits for diabetes management 3. Patients aged between 21 and 70 years old

Exclusion criteria

Exclusion criteria: 1. Severe comorbid conditions 2. Pregnancy 3. Cognitive impairments 4. Unable to comply with the study procedures or provide informed consent

Design outcomes

Primary

Measure	Time frame
Glycaemic control is measured via glycosylated Haemoglobin (HbA1c) at baseline, week 12 and week 24	—

Secondary

Measure	Time frame
1. Cardiometabolic parameters measured via Low-Density Lipoprotein (Measured) (LDL-M), weight, Body Mass Index (BMI), and blood pressure at baseline, week 12 and week 24 2. Satisfaction measured using the Glucose Monitoring Satisfaction Survey (GMSS) at baseline and week 24 3. Diabetes-related distress measured using the Problem Area In Diabetes (PAID) scale at baseline and week 24	—

Countries

Singapore

Contacts

Public ContactXia Lian

lian_xia@ttsh.com.sg+65 (0)63571000

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026